Smith & Nephew plc (SN.), the global medical technology company, has disclosed the repurchase of 1,061,205 of its own ordinary shares between 11 and 13 November 2026, executed through Merrill Lynch International on the London Stock Exchange. The buyback, costing $16,452,097.59 in aggregate, forms part of the programme announced on 6 May 2026 and approved by shareholders at the company's Annual General Meeting on the same date. The disclosure is significant for investors as it reduces the number of voting shares in circulation and updates the denominator used to calculate notifiable interests under FCA transparency rules.

Key Points

  • Smith & Nephew plc (SN.) — FTSE-listed global medical technology group
  • 1,061,205 ordinary shares of US 20¢ each repurchased between 11 and 13 November 2026 via Merrill Lynch International
  • Aggregate cost of $16,452,097.59; volume-weighted average price of 1,166.73p per share on the London Stock Exchange
  • Investors should monitor the total treasury share count and any future announcement regarding cancellation or use in employee share plans

Daily Breakdown of Smith & Nephew's Share Purchases from 11 to 13 November 2026

The company purchased 398,814 shares on 11 November 2026 at prices ranging from 1,140.50p to 1,160.00p, with an average of 1,153.46p. On 12 November 2026, 347,610 shares were acquired at an average price of 1,174.02p, with prices between 1,165.50p and 1,184.00p. The final day of the disclosed period, 13 November 2026, saw 314,781 shares purchased, also within the 1,165.50p to 1,184.00p range, at an average of 1,175.50p. All transactions were conducted exclusively on the London Stock Exchange, with no volume recorded on alternative venues including CBOE Europe, Turquoise, or Aquis.

Treasury Share Position and Updated Denominator for FCA Transparency Reporting

Following these purchases, Smith & Nephew now holds 41,134,166 ordinary shares in treasury. The company's issued share capital, excluding treasury shares, stands at 836,615,908 ordinary shares, each carrying one voting right. Under the FCA's Disclosure Guidance and Transparency Rules, shareholders are required to use this figure of 836,615,908 as the denominator when calculating whether they must notify changes to their interests in the company. This denominator is a key reference point for institutional and significant retail shareholders managing their disclosure obligations.

Share Buyback Programme Authorised at Smith & Nephew's May 2026 AGM

The buyback programme was first announced on 6 May 2026, with shareholder authority granted at the Annual General Meeting held on the same date. The repurchases comply with UKLR 9.6.6R and were made in accordance with Article 5(1)(b) of Regulation (EU) No 596/2014, as incorporated into UK domestic law. The company states that the acquired shares will be held in treasury, with a decision to follow on whether they will be cancelled outright or retained to satisfy awards under Smith & Nephew's employee share plans — a distinction that affects the future dilution profile for existing shareholders.